BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 18619196)

  • 1. Wegener's granulomatosis effectively treated with rituximab: a case study.
    Kowalewska B; Szechiński J; Roszkowska E
    Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.
    Specks U; Fervenza FC; McDonald TJ; Hogan MC
    Arthritis Rheum; 2001 Dec; 44(12):2836-40. PubMed ID: 11762944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
    Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wegener's granulomatosis: a diagnostic challenge.
    Zubairi AB; Liaquat HB; Husain SJ; Fatima K
    J Pak Med Assoc; 2009 Dec; 59(12):853-5. PubMed ID: 20201181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab induced remission in a patient with Wegener's granulomatosis.
    Kallenbach M; Duan H; Ring T
    Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
    Tamura N; Matsudaira R; Hirashima M; Ikeda M; Tajima M; Nawata M; Morimoto S; Kaneda K; Kobayashi S; Hashimoto H; Takasaki Y
    Intern Med; 2007; 46(7):409-14. PubMed ID: 17409608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of rituximab in refractory Wegener's granulomatosis with central nervous system involvement].
    Kowalewska B; Krywejko J; Roszkowska E
    Ann Acad Med Stetin; 2010; 56 Suppl 1():99-104. PubMed ID: 21365953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological therapy for Wegener's granulomatosis.
    White ES; Lynch JP
    Drugs; 2006; 66(9):1209-28. PubMed ID: 16827598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wegener's granulomatosis--exacerbation with pulmonary manifestation.
    Matysiak M; Stasiuk M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):317-21. PubMed ID: 12898856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wegener's granulomatosis with anti-neutrophil cytoplasmic antibodies against anti-cathepsin G antigen].
    Ocaña Pérez E; Peña Casas AM; del Campo Muñoz T; Avila Casas A; Luque Barona R
    An Pediatr (Barc); 2013 Dec; 79(6):381-4. PubMed ID: 23602835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
    Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
    Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.